Primary care clinicians are called on to care for adolescents in a time with increasing pharmacologic agents that are available in the management of these patients. The emphasis in this book is on the current pharmacologic treatment of common medical disorders in adolescents. Selected topics of practical relevance in adolescent medicine are covered. The goal of this book is to provide a succinct and practical guide specifically written for practicing physicians and allied health professionals who work with adolescents.

Donald E. Greydanus, Dilip R. Patel, Michigan State University, Kalamazoo Center for Medical Studies, Kalamazoo, United States; Hatim A. Omar, Division of Adolescent Medicine, University of Kentucky, Lexington, United States; Cynthia Feucht, Ferris State University, School of Pharmacy, Kalamazoo, United States; Joav Merrick, National Institute of Child Health and Human Development and Health Services, Ministry of Social Affairs, Jerusalem, Israel.

1;Forword;17 2;Contributors;21 3;Abbreviations;25 4;1 Introduction - Pharmacotherapeutics in medical disorders;37 5;2 Dermatology;43 5.1;2.1 Introduction;43 5.2;2.2 Skin Infections and Infestations;43 5.2.1;2.2.1 Bacterial infections;43 5.2.2;2.2.2 Viral infections;53 5.2.3;2.2.3 Fungal infections;59 5.2.4;2.2.4 Infestations;62 5.3;2.3 Dermatitis;65 5.3.1;2.3.1 Nonallergic dermatitis;65 5.3.2;2.3.2 Allergic dermatitides;66 5.3.3;2.3.3 Idiopathic dermatitides;69 5.4;2.4 Hypersensivity;70 5.4.1;2.4.1 Urticaria;70 5.4.2;2.4.2 Erythema multiforme;71 5.4.3;2.4.3 Drug eruptions;71 5.5;2.5 Miscellaneous Skin Conditions;73 5.5.1;2.5.1 Acne vulgaris;73 5.5.2;2.5.2 Nevi;76 5.5.3;2.5.3 Papulosquamous disorders;79 5.6;2.6 Dermatologic manifestations of systematic disorders;86 5.6.1;2.6.1 Pruritus without rash;86 5.6.2;2.6.2 Inflammatory bowel disease (IBD);86 5.6.3;2.6.3 Erythema nodosum;87 5.6.4;2.6.4 Pyoderma gangrenosum;87 5.6.5;2.6.5 Less common skin manifestations;87 5.6.6;2.6.6 Management;87 5.7;2.7 Collagen Vascular Disease;87 5.7.1;2.7.1 Lupus erythematosus (LE);87 5.7.2;2.7.2 Dermatomyositis;88 5.7.3;2.7.3 Juvenile idiopathic arthritis (JIA);88 5.7.4;2.7.4 Management;88 5.8;2.8 Endocrinologic Disorders;88 5.8.1;2.8.1 Thyroid disorders;88 5.8.2;2.8.2 Diabetes mellitus;89 5.8.3;2.8.3 Adrenal disorders;89 5.8.4;2.8.4 Management;89 5.9;2.9 Hair and Nails;89 5.9.1;2.9.1 Alopecia areata;89 5.9.2;2.9.2 Management of alopecia areata;90 5.9.3;2.9.3 Telogen effluvium;91 5.9.4;2.9.4 Androgenic alopecia;91 5.9.5;2.9.5 Trichotillomania;92 5.9.6;2.9.6 Traction alopecia;92 5.9.7;2.9.7 Hirsutism and hypertrichosis;92 5.9.8;2.9.8 Hair changes with systemic disease;93 5.9.9;2.9.9 Infection;93 5.9.10;2.9.10 Herpetic whitlow;94 5.9.11;2.9.11 Bacterial;94 5.9.12;2.9.12 Ingrown nail;95 5.9.13;2.9.13 Fungal;95 5.9.14;2.9.14 Onychodystrophy;96 5.9.15;2.9.15 Nail changes with systemic and nutritional disorders;97 5.10;2.10 Summary;98 6;3 Disorders of the endocrine system;101 6.1;3.1 Introduction;101 6.2;3.2 Thyroid Hormone Disorders;101 6.2.1;3.2.1 Hypothyroidism;101 6.2.2;3.2.2 Hyperthyroidism;102 6.3;3.3 Central Diabetes Insipidus (DI);104 6.4;3.4 Adrenal Gland Disorders;105 6.4.1;3.4.1 Hypoadrenocorticism;106 6.4.2;3.4.2 Hyperadrenocorticism;107 6.5;3.5 Disorders of Vitamin D, Calcium Metabolism, and Parathyroid Hormone;108 6.5.1;3.5.1 Rickets;108 6.5.2;3.5.2 Hypocalcemia;110 6.5.3;3.5.3 Hypercalcemia;110 6.6;3.6 Disorders of Pubertal Development;111 6.6.1;3.6.1 Normal pubertal development in girls;111 6.6.2;3.6.2 Gonadotropin-independent or peripheral precocious puberty (PPP);113 6.6.3;3.6.3 Delayed puberty;114 6.7;3.7 Growth Disorders;116 6.7.1;3.7.1 Short stature;116 6.7.2;3.7.2 Tall stature;119 6.8;3.8 Polycystic Ovarian Syndrome (PCOS);119 6.9;3.9 Diabetes Mellitus (DM);120 6.9.1;3.9.1 Epidemiology;120 6.9.2;3.9.2 Etiopathogenesis;120 6.9.3;3.9.3 Clinical presentation;121 6.9.4;3.9.4 Diagnostic criteria;121 6.9.5;3.9.5 Management;121 6.10;3.10 Conclusions;126 7;4 Neurologic disorders;129 7.1;4.1 Epilepsy;129 7.1.1;4.1.1 Epidemiology;129 7.1.2;4.1.2 Classification;129 7.1.3;4.1.3 Differential diagnosis;129 7.1.4;4.1.4 Management;130 7.1.5;4.1.5 Seizure prophylaxis;132 7.1.6;4.1.6 Medications commonly used for focal epilepsy;134 7.1.7;4.1.7 Acute seizure management for status epilepticus;134 7.2;4.2 Headaches;135 7.2.1;4.2.1 Epidemiology;135 7.2.2;4.2.2 Headache classification;135 7.2.3;4.2.3 Management;135 7.3;4.3 Tic disorders;138 7.3.1;4.3.1 Epidemiology;139 7.3.2;4.3.2 Differential diagnosis/diagnostic evaluation;139 7.3.3;4.3.3 Treatment;140 7.4;4.4 Tremor;145 7.4.1;4.4.1 Epidemiology;145 7.4.2;4.4.2 Differential diagnosis;145 7.5;4.5 Conclusions;149 8;5 Gastrointestinal disorders;155 8.1;5.1 Irritable bowel syndrome;155 8.1.1;5.1.1 Epidemiology;155 8.1.2;5.1.2 Differential diagnosis;155 8.1.3;5.1.3 Management;156 8.2;5.2 Constipation;156 8.2.1;5.2.1 Epidemiology;157 8.2.2;5.2.2 Differential diagnosis;157 8.2.3;5.2.3 Management;158 8.3;5.3 Gas